
Danaher Corporation DHR
Country |
|
IPO year |
- |
Industry |
Diagnostics research |
Stock Exchange |
NYSESPB |
Shares |
713 M |
Market Cap[1] |
$ 159 B |
EBITDA (LTM) |
$ 5.44 B |
P/E (LTM) |
40.95858 |
P/S (LTM) |
6.024067 |
EPS (LTM) |
5.07 |
Danaher Corporation is an American diversified conglomerate that manufactures and sells a wide range of industrial and scientific products. Founded in 1984, the company is now one of the largest corporations in the world. Product portfolio includes tools for medical and scientific research, industrial automation and quality control systems, water analysis equipment, and many other goods. The company offers its products in more than 125 countries around the world.
One of Danaher Corporation's key principles is continuous development and innovation. The company invests significant resources in scientific research and the development of new technologies, which has helped it to achieve leading positions in many industries. Also known for its management strategy, called the Danaher Business System (DBS). This system is based on Lean Manufacturing and Six Sigma principles and enables the company to effectively manage its processes and achieve high results.
Overall, it's a successful and innovative company that holds leading positions in many industries. Thanks to its management strategy and constant investments in scientific research, the company continues to grow and attract new customers from all over the world.
Other stocks of industry "Diagnostics research"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Biomerica
BMRA
|
$ 2.46 | 0.36 % | $ 7.17 M | Nasdaq Capital Market | ||
|
CareDx, Inc
CDNA
|
$ 61.37 | 13.0 % | $ 3.27 B | Nasdaq Global Market,SPB | ||
|
Celcuity
CELC
|
$ 79.37 | 0.12 % | $ 3.71 B | Nasdaq Global Select Market | ||
|
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | ||
|
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | ||
|
Co-Diagnostics
CODX
|
$ 1.15 | 4.55 % | $ 1.53 M | Nasdaq Capital Market | ||
|
Castle Biosciences
CSTL
|
$ 35.19 | 0.89 % | $ 1.02 B | Nasdaq Global Market,SPB | ||
|
DexCom
DXCM
|
$ 87.47 | 0.21 % | $ 34.1 B | Nasdaq Global Select Market,SPB | ||
|
Fulgent Genetics
FLGT
|
$ 21.55 | 1.32 % | $ 663 M | Nasdaq Global Market | ||
|
Guardant Health
GH
|
$ 176.45 | 0.08 % | $ 22.1 B | Nasdaq Global Select Market,SPB | ||
|
ICON Public Limited Company
ICLR
|
$ 173.9 | 6.1 % | $ 13.6 B | Nasdaq Global Select Market,SPB | ||
|
IDEXX Laboratories
IDXX
|
$ 513.39 | 0.07 % | $ 41.3 B | Nasdaq Global Select Market,SPB | ||
|
IQVIA Holdings
IQV
|
$ 275.02 | 2.67 % | $ 47.3 B | NYSE,SPB | ||
|
Laboratory Corporation of America Holdings
LH
|
$ 308.95 | 1.47 % | $ 25.7 B | NYSE,SPB | ||
|
Lantheus Holdings
LNTH
|
$ 99.72 | 0.01 % | $ 6.73 B | Nasdaq Global Select Market,SPB | ||
|
Biodesix
BDSX
|
$ 29.4 | 0.38 % | $ 222 M | Nasdaq Global Market | ||
|
Medpace Holdings
MEDP
|
$ 620.59 | 0.56 % | $ 17.9 B | Nasdaq Global Select Market,SPB | ||
|
Mettler-Toledo International
MTD
|
$ 1 519.15 | 1.8 % | $ 31.3 B | NYSE,SPB | ||
|
Myriad Genetics
MYGN
|
$ 4.14 | 3.24 % | $ 383 M | Nasdaq Global Select Market,SPB | ||
|
ENDRA Life Sciences
NDRA
|
$ 5.93 | 2.0 % | $ 4.67 M | Nasdaq Global Select Market | ||
|
NeoGenomics
NEO
|
$ 19.56 | 6.54 % | $ 2.51 B | Nasdaq Global Select Market,SPB | ||
|
Neogen Corporation
NEOG
|
$ 13.66 | 0.66 % | $ 2.97 B | Nasdaq Global Select Market,SPB | ||
|
Syneos Health
SYNH
|
- | - | $ 4.46 B | Nasdaq Global Select Market,SPB | ||
|
Natera
NTRA
|
$ 408.79 | 4.61 % | $ 55.9 B | Nasdaq Global Select Market,SPB | ||
|
OPKO Health
OPK
|
$ 1.64 | 0.29 % | $ 1.23 B | Nasdaq Global Select Market | ||
|
Anixa Biosciences
ANIX
|
$ 2.78 | 1.09 % | $ 90.2 K | Nasdaq Capital Market | ||
|
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | ||
|
RadNet
RDNT
|
$ 71.31 | 0.04 % | $ 5.36 B | Nasdaq Global Select Market | ||
|
Renalytix AI plc
RNLX
|
- | 5.66 % | $ 22.7 M | Nasdaq Global Market | ||
|
Senseonics Holdings
SENS
|
$ 10.34 | 3.66 % | $ 431 M | NYSE American | ||
|
Sotera Health Company
SHC
|
$ 18.45 | 0.87 % | $ 5.24 B | Nasdaq Global Select Market | ||
|
Neuronetics
STIM
|
$ 2.82 | 0.21 % | $ 186 M | Nasdaq Global Select Market | ||
|
Trinity Biotech plc
TRIB
|
$ 6.95 | 0.68 % | $ 2.5 B | Nasdaq Global Select Market | ||
|
Twist Bioscience Corporation
TWST
|
$ 184.03 | 16.11 % | $ 11 B | Nasdaq Global Select Market,SPB | ||
|
VolitionRx Limited
VNRX
|
$ 0.25 | 2.9 % | $ 31.4 M | NYSE American | ||
|
Waters Corporation
WAT
|
$ 430.3 | 2.31 % | $ 25.6 B | NYSE,SPB | ||
|
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | ||
|
Exagen
XGN
|
$ 8.74 | 2.22 % | $ 188 M | Nasdaq Global Market | ||
|
Psychemedics Corporation
PMD
|
- | -1.84 % | $ 15.3 M | Nasdaq Global Select Market | ||
|
T2 Biosystems
TTOO
|
- | -39.35 % | $ 313 K | Nasdaq Global Select Market | ||
|
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | ||
|
Meridian Bioscience
VIVO
|
- | - | $ 1.49 B | Nasdaq Global Select Market | ||
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market | ||
|
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | ||
|
Quotient Limited
QTNT
|
- | -11.32 % | $ 1.1 M | Nasdaq Global Select Market | ||
|
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | ||
|
BioNano Genomics
BNGO
|
$ 1.69 | 0.29 % | $ 9.2 M | Nasdaq Capital Market,SPB | ||
|
Burning Rock Biotech Limited
BNR
|
$ 18.0 | 19.4 % | $ 194 M | Nasdaq Global Market | ||
|
Bioventus
BVS
|
$ 13.52 | 0.07 % | $ 901 M | Nasdaq Global Select Market |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.